Commercial & Medical Affairs - software & AI news

Daily news on software, AI, and companies shaping commercial & medical affairs.

Showing 82 results
Minimalist illustration of a pill and data flow diagram in dark colors.

Jun 2, 2026

Connect Commercial Models to Improve Decision-Making in the Pharma AI Era, Upcoming Webinar Hosted by Xtalks

The upcoming webinar titled "Connect Commercial Models to Improve Decision-Making in the Pharma AI Era" will delve into how AI can enhance decision-making within pharmaceutical organizations.The event will focus on the transition from fragmented engagement strategies to more integrated commercial models, emphasizing the importance of governance and trust in AI-driven workflows. Attendees will explore how aligning medical, marketing, and sales functions through shared insights can lead to more ef
A vial of medication on a lab bench

Jun 2, 2026

Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma

Salesforce has recently reported that over 140 life sciences organizations, including major players like Novartis and AstraZeneca, are utilizing its Agentforce Life Sciences platform. This announcement came during the Veeva Commercial Summit, where Salesforce emphasized its AI-driven approach across various engagement areas in the life sciences sector.Joe Ferraro, Salesforce's SVP and GM of life sciences, highlighted that their platform supports a wide array of functions, from patient and clinic
A pill bottle on a desk in a dimly lit office

May 28, 2026

Solstice Secures $21M for AI-Native Pharmaceutical Marketing Platform

Solstice, an AI-driven pharmaceutical marketing platform, has raised $21 million in Series A funding led by Transformation Capital, increasing its total funding to about $25 million. This investment aims to enhance its technical infrastructure and expedite its market entry strategies.The company addresses significant delays in pharmaceutical marketing, where the review process for marketing materials can take up to three months due to stringent medical, legal, and regulatory (MLR) checks. By int
A minimalist illustration of a pill on a solid background.

May 28, 2026

Solstice: $21 Million Series A Raised To Accelerate Pharma Commercialization

Solstice, an AI-driven marketing agency, has successfully raised $21 million in Series A funding, aimed at enhancing the commercialization processes for pharmaceuticals. This funding round, led by Transformation Capital, brings the company's total funding to around $25 million.This new investment will facilitate Solstice's expansion into the market, drive product development, and enhance team capabilities in both product and customer-facing roles. The agency is dedicated to streamlining the comm
A printed healthcare provider directory on a wooden desk in a modern office.

May 28, 2026

H1 Receives $40M Investment in Round Led by CVS Health Ventures

H1, a company focused on enhancing healthcare operations through AI, has secured a significant $40 million investment led by CVS Health Ventures. This funding aims to bolster their ongoing initiatives to improve healthcare provider connections and streamline patient access to care.The investment from CVS Health Ventures, which is dedicated to fostering healthcare innovation, follows a series of successful collaborations between the two entities. Notably, they have developed an AI model that sign
A pill bottle on a desk with marketing materials in a dimly lit office.

May 28, 2026

AI-native pharma marketing startup Solstice raises $21M to cut drug campaign timelines from 3 months to 10 days

AI-driven startup Solstice has successfully raised $21 million in Series A funding to revolutionize pharmaceutical marketing timelines, reducing the approval process from months to mere days.Based in New York, Solstice aims to streamline the traditionally cumbersome marketing and regulatory review processes in the pharmaceutical industry. With over a dozen pharmaceutical partners, including major global brands, the startup leverages AI to cut the time from content creation to regulatory submissi
A prescription pad and pill bottle on a desk in a dimly lit office

May 18, 2026

Claritas Rx Expands Leadership Team as Specialty Pharma Turns to AI-Driven Patient Access Platforms

Claritas Rx is enhancing its leadership team to better address the evolving needs of specialty pharmaceuticals, particularly through AI-driven patient access solutions.The company has appointed Keith Pensabene as chief revenue officer and promoted Meghna Misra and Shelly Howard to vice president roles. These changes aim to bolster revenue growth and operational efficiency, aligning with the increasing investment in technology platforms that facilitate patient onboarding, reimbursement navigation
A minimalist illustration of a cloud and data stream representing AI in life sciences.

May 18, 2026

Anthill Cloud - an AI-Powered Content Excellence Platform for the US Life Sciences Market

Anthill has launched Anthill Cloud™, an innovative platform designed to enhance content creation and engagement in the US life sciences sector, particularly for pharmaceutical and biotech companies.The Anthill Cloud™ platform integrates generative AI, modular content authoring, and HCP (Healthcare Professional) engagement into a single, compliant ecosystem. This strategic tool addresses the growing complexity faced by US life science teams, such as the demand for personalized communications, the
Flat illustration of pharmaceutical promotional materials and structured data

May 18, 2026

Shaman Launches Shaman Atlas to Convert Pharma's Approved Content Into Structured Data

Shaman has introduced Shaman Atlas, a groundbreaking AI-driven tool designed to transform pharmaceutical promotional materials into structured, reusable data.This innovative solution addresses a significant challenge faced by large pharmaceutical companies, which typically manage over 400,000 approved promotional files. These files often contain crucial information, such as validated claims and regulatory content, but are locked in flat formats that hinder effective extraction and reuse. Shaman
A minimalist cloud icon symbolizing cloud computing in life sciences.

May 17, 2026

Veeva Systems stock (US9224171002): earnings spotlight and cloud strategy for life sciences

Veeva Systems has recently shared its quarterly results and updated forecasts, capturing investor interest in the life sciences sector.Veeva Systems, a key player in cloud software for the life sciences industry, has reported its fiscal fourth quarter and full-year results, alongside an updated outlook for fiscal 2026. The company's stock reacted positively on the NYSE following the announcement, which highlighted significant revenue growth and profitability trends. For the fiscal year 2025, Vee
A clipboard and notepad in a pharmaceutical office setting

May 15, 2026

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

Virtual Science AI has introduced Medical Competitor AI, a pioneering platform designed to enhance the success of pharmaceutical asset launches by tracking competitor activities and scientific narratives.This innovative AI-driven platform stands out in the life sciences sector by providing comprehensive insights into competitor medical activities, including conference participation, social media engagement, and publication trends. Traditionally, such analyses have been labor-intensive and often
A drug compound vial on a lab bench with research papers in the background.

May 15, 2026

EQS-News: Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success - boerse.de

Virtual Science AI has unveiled Medical Competitor AI, a pioneering platform designed to track competitor activities and scientific narratives in the pharmaceutical industry. This innovative tool aims to enhance the success of new drug launches by providing real-time insights into competitors' actions and strategies.The Medical Competitor AI platform enables pharmaceutical teams to analyze various aspects of competitor engagement, including conference presentations, social media interactions, an